Download PDF
Thromb Haemost 1986; 56(02): 237
DOI: 10.1055/s-0038-1661649
Letter to the Editor
Schattauer GmbH Stuttgart

Antithrombin III (ATIII) and Heparin Cofactor II (HCII) in Normal Human Fetuses (21st-27th Week)

Pierre Toulon
1   Laboratoire d’Hematologie, UER de Biologie expérimentale et humaine, 4, avenue de l’Observatoire, 75270 Paris Cedex 06, France
,
Martine Rainaut
2   Centre de Diagnostic Prénatal et de Foetologie, Hopital Notre Dame de Bon-Secours, 66, rue des Plantes, 75674 Paris Cedex 14, France
,
Martine Aiach
1   Laboratoire d’Hematologie, UER de Biologie expérimentale et humaine, 4, avenue de l’Observatoire, 75270 Paris Cedex 06, France
,
Martine Roncato
1   Laboratoire d’Hematologie, UER de Biologie expérimentale et humaine, 4, avenue de l’Observatoire, 75270 Paris Cedex 06, France
,
Fernand Daffos
2   Centre de Diagnostic Prénatal et de Foetologie, Hopital Notre Dame de Bon-Secours, 66, rue des Plantes, 75674 Paris Cedex 14, France
,
François Forestier
2   Centre de Diagnostic Prénatal et de Foetologie, Hopital Notre Dame de Bon-Secours, 66, rue des Plantes, 75674 Paris Cedex 14, France
› Author Affiliations
Further Information

Publication History

Received 16 June 1986

Accepted 08 July 1986

Publication Date:
26 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Malia RG, Preston FE, Mitchell VE. Evidence against Vitamin K deficiency in normal neonates. Thromb Haemostas 1980; 44: 159-160
    PubMedGoogle Scholar
  • 2 Forestier F, Daffos F, Rainaut M, Sole Y, Amiral J. Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy. Thromb Haemostas 1985; 53: 401-403
    PubMedGoogle Scholar
  • 3 Griffith MJ, Noyes CM, Church FC. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J Biol Chem 1985; 260: 2218-2225
    PubMedGoogle Scholar
  • 4 Leon M, Aiach M, Coezi E, Guennec JY, Fiessinger JN. Antithrombin III synthesis in rat liver parenchymal cells. Thromb Res 1983; 30: 369-375
    CrossrefPubMedGoogle Scholar
  • 5 Tollefsen DM, Pestka CA. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure. Blood 1985; 66: 769-774
    PubMedGoogle Scholar
  • 6 Jaffe EA, Armellino D, Tollefsen DM. Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line. Biochem Biophys Res Commun 1985; 132: 368-374
    CrossrefPubMedGoogle Scholar
  • 7 Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound. A study of 606 consecutive cases. Am J Obst Gynecol 1985; 153: 655-660
    CrossrefPubMedGoogle Scholar
  • 8 Desmonts G, Daffos F, Forestier F, Thuilliez P, Capella-Pavlovsky M, Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet 1985; 1: 500-503
    PubMedGoogle Scholar
  • 9 Aiach M, Leon M, Michaud A, Capron L. Adaptation of synthetic peptide substrate-based assays on a discrete analyser. Semin Thromb Hemostasis 1983; 9: 206-216
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest 1972; (Suppl. 29) suppl 124: 21-37
    PubMedGoogle Scholar
  • 11 Cederholm-Williams SA, Spencer JA D, Wilkinson AR. Plasma levels of selected haemostatic factors in newborn babies. Thromb Res 1981; 23: 555-558
    CrossrefPubMedGoogle Scholar
  • 12 Peters M, Jansen E, Ten Cate JW, Kahle LH. Neonatal antithrombin III. Brit J Haematol 1984; 58: 579-587
    CrossrefPubMedGoogle Scholar